A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2)
Ovarian CancerEpithelial Ovarian CancerFallopian Tube CancerPeritoneal Cancerprimary peritoneal cancerplatinum sensitiverelapsed diseasePARP Inhibitorrucaparibhomologous recombinationhomologous recombination deficiencygenomic scarringloss of heterozygosityCO-338PF 01367338AG 14699platinum sensitive ovarian cancerplatinum sensitive fallopian tube cancerplatinum sensitive primary peritoneal cancerplatinum sensitive peritoneal cancergynecological cancerClovisClovis OncologyARIEL2ARIEL 2ARIEL3ARIEL 3Ovarian NeoplasmsCarcinoma, Ovarian EpithelialFallopian Tube NeoplasmsPeritoneal NeoplasmsHypersensitivityOral rucaparib
Lead Scientist at UCSF
- Lee-May Chen
Dr. Lee-may Chen is the Division Director and Program Director for the UCSF/KPSF Gynecologic Oncology Fellowship Program. She is deeply committed to education and improving the outcomes of gynecologic cancer care. Since 2008, I have been the director of the UCSF Gynecologic Cancer Risk Program.